![]() |
市场调查报告书
商品编码
1825964
2025年流式细胞技术全球市场报告Flow Cytometry Global Market Report 2025 |
近年来,流式细胞技术市场规模强劲成长,从2024年的68.8亿美元增加至2025年的74.9亿美元,复合年增长率为8.8%。预测期内的成长主要归功于免疫表型分析、癌症研究、血液学和血球分析、临床诊断、药物研发。
预计未来几年流式细胞技术市场将快速成长,到2029年将达到115亿美元,复合年增长率为11.3%。预测期内的成长主要由单细胞分析、免疫疗法和CAR-T细胞开发、感染疾病研究、生物标记发现以及即时检测等驱动。预测期内的主要趋势包括多色分析、自动化和机器人技术、成像流式细胞技术、数据分析和资讯技术以及样品製备的创新。
流式细胞技术是一种将细胞导入流体介质中,并使其通过脉衝雷射光束的技术。当细胞将雷射散射到不同方向时,受体会捕捉光并将其转换为数据显示在显示器上。此方法利用雷射光学元件来分析生物细胞的特征,例如大小、数量和复杂性。
流式细胞技术采用多种技术,包括基于细胞和以微珠为基础的方法,其应用范围涵盖肿瘤学、药物研发、疾病诊断、干细胞治疗、器官移植和血液学。该技术服务于各种终端用户,包括医院和诊所、学术和研究机构、製药和生物技术公司以及其他行业,推动科学研究和医疗保健实践的发展。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响,尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本,而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力,一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外,原料和零件的关税扰乱了关键药品和医疗设备的生产,导致供应链延迟。作为应对措施,该行业正在采用多样化的筹资策略,尽可能扩大本地生产,并游说对关键医疗产品免关税。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供流式细胞技术市场统计数据,例如全球流式细胞流式细胞技术市场规模、各地区市场份额、竞争对手的市场份额、详细的流式细胞技术流式细胞技术细分市场、市场趋势和机会,以及您在流式细胞技术行业取得成功所需的数据。本流式细胞技术市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年11.3%的成长预测较先前的预测略有下降,下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将提高美国从奥地利和新加坡购买的流式细胞技术分析仪和萤光抗体的成本,减缓免疫表型分析的速度,并增加临床实验室的营运成本。互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响也将产生更广泛的影响。
全球HIV感染人数的不断增加是流式细胞技术市场发展的关键驱动力。流式细胞技术利用光散射来区分细胞,并根据细胞的散射模式,用被称为分化丛集(CD)的特定标记物对其进行标记。例如,2023年10月,英国卫生安全局报告称,英格兰的HIV诊断数量增加了22%,从2021年的3,118例增加到2022年的3,805例。随着全球HIV感染人数的持续上升,对流式细胞技术等诊断方法的需求也在增加。
新药上市数量的增加也促进了流式细胞技术市场的扩张。新药上市涉及经过广泛研发后,透过监管部门核准、行销和分销将新药推向市场。流式细胞技术在新药上市过程中发挥关键作用,它透过评估细胞反应、药物疗效和毒性来确保安全有效的药物上市。流式细胞技术有助于准确表征,这对于监管部门核准和上市后监控至关重要。例如,欧洲製药工业协会联合会 (European Federation of Pharmaceutical Industries and Associations) 在 2023 年 6 月报告称,到 2022 年,北美将占全球药品销售额的 52.3%,市场份额将比 2021 年的 49.1% 大幅增长。因此,新药上市数量的增加正在推动流式细胞技术市场的成长。
流式细胞技术市场的主要企业正致力于开发先进产品,例如研究级流式细胞仪,以提高细胞分析的灵敏度和解析度。研究级流式细胞仪用于科学研究,以检查流经液流的细胞和颗粒的物理和化学特性。这些仪器采用先进的光学系统和软体,能够侦测多种萤光标记,为多参数细胞分析提供高灵敏度和解析度。这项技术在免疫学、肿瘤学和细胞生物学等领域至关重要。例如,2024 年 3 月,专门从事生物医学检测产品的美国公司贝克曼库尔特生命科学公司推出了 CytoFLEX 奈米流式细胞仪。该系统可以检测到小至 40 奈米的奈米颗粒,使其能够有效地分析细胞外囊泡 (EV) 和其他奈米级实体。凭藉 1 μm 至 40 nm 的灵敏度和 10 nm 的分辨率,它可以检测到 EV 内的低丰度物质。这种提高的灵敏度对于准确表征小颗粒群至关重要。该系统配备六个萤光和五个侧向散射通道,可同时收集多个参数的大量数据。此外,它还包含 CytExpert nano 软体,该软体支援高级研究,同时提供直觉的介面,简化复杂的分析。
流式细胞技术市场的公司也专注于开发创新产品,例如自动化样品製备系统,可减少技术人员的时间,同时提供更快、更准确的结果。自动化样品製备系统透过自动执行混合、染色和稀释等任务来简化实验室流程,确保样品製备的一致性和准确性。这不仅最大限度地减少了人工,还提高了效率,使其成为高性能实验室和临床诊断的理想选择。例如,美国医疗设备公司Becton Dickinson于2023年6月推出了BD FACSDuet。这款高阶样品製备系统旨在与BD FACSLyric临床流式细胞技术系统无缝集成,实现全自动「无人值守」工作流程。它可自动执行样品混合、清洗和离心等关键流程。样品製备后,无需人工干预即可将样品转移到流式细胞仪,从而减少了手动步骤和操作时间。该系统显着提高了临床诊断的标准化和可重复性,并提高了实验室的整体效率。
2022年2月,总部位于美国的GLP和GCP合规开发服务供应商KCAS Bioanalytical and Biomarker Services收购了FlowMetric LLC,收购金额未揭露。此次收购预计将增强KCAS在分析测试领域的能力。 FlowMetric是一家总部位于美国的流式细胞技术和细胞检测服务提供者。
流式细胞仪市场的主要企业包括 Beckman Coulter Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、Thermo Fisher Scientific Inc.、Luminex Corporation、Miltenyi BIoTec Ltd.、Becton Dickinson and Company、Sysmex Corporation、Merck KGaA、Docistal Corporation.Dcx 流式细胞技术 Corporation.公司、Affymetrix Inc.、Biomerieux SA、Cytonome St LLC、Enzo Life Sciences Inc.、Sony Biotechnology Inc.、Life Technologies Corporation、ACEA Biosciences Inc.、Takara Bio Inc.、Union Biometrica Inc.、Cytek Biosciences Inc Cy.、Nexcelom Bioscience LLC、Verity Software
2024年,流式细胞技术市场最大的地区是北美。西欧是流式细胞技术市场分析的第二大地区。流式细胞技术市场报告涵盖以下地区:亚太地区、西欧、东欧、北美、南美以及中东和非洲。
流式细胞技术市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
流式细胞技术市场涵盖流式细胞仪系统、检测板製造商和仪器的收益。市场规模包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括企业之间交易或销售给最终消费者的商品和服务。
Flow cytometry is a technique where cells are introduced into a fluid medium that is passed through a pulsating laser beam. As the cells scatter the laser beam in various directions, receptors capture the light and convert it into data displayed on a monitor. This method is used to analyze biological cell characteristics, such as size, count, and complexity, utilizing laser optics.
Flow cytometry employs different technologies, including cell-based and bead-based methods, with applications spanning oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and hematology. This technology serves a diverse range of end-users, including hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, as well as other sectors, to advance scientific research and healthcare practices.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The flow cytometry market research report is one of a series of new reports from The Business Research Company that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares, competitors with a flow cytometry market share, detailed flow cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry industry. This flow cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The flow cytometry market size has grown strongly in recent years. It will grow from $6.88 billion in 2024 to $7.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to immunophenotyping, cancer research, hematology and blood cell analysis, clinical diagnostics, drug discovery and development.
The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $11.5 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to single-cell analysis, immunotherapy and car-t cell development, infectious disease research, biomarker discovery, point-of-care testing (poct). Major trends in the forecast period include multicolor analysis, automation and robotics, imaging flow cytometry, data analysis and informatics, sample preparation innovations.
The forecast of 11.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of flow cytometry analyzers and fluorescent antibodies sourced from Austria and Singapore, thereby slowing immunophenotyping and elevating clinical lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising global number of HIV cases is a key driver for the flow cytometry market, as this technique plays a direct role in HIV diagnosis. Flow cytometry utilizes light scattering to identify cells, which are labeled with specific markers known as CDs (clusters of differentiation) based on the scattering pattern. For example, in October 2023, the UK Health Security Agency reported a 22% increase in HIV diagnoses in England, rising from 3,118 cases in 2021 to 3,805 in 2022. As the global HIV population continues to rise, the demand for diagnostic methods like flow cytometry is also growing.
The growth in drug launches has also contributed to the expansion of the flow cytometry market. Drug launches involve introducing new pharmaceutical products to the market, following regulatory approval, marketing, and distribution after extensive research and development. Flow cytometry plays a critical role in drug launches by evaluating cellular responses, drug efficacy, and toxicity, ensuring that safe and effective medications are brought to market. It helps with accurate characterizations essential for regulatory approval and post-launch monitoring. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations reported that North America accounted for 52.3% of global pharmaceutical sales in 2022, up from 49.1% in 2021, highlighting a significant market share increase. Thus, the rise in drug launches is driving growth in the flow cytometry market.
Leading companies in the flow cytometry market are concentrating on the development of advanced products, such as research-grade flow cytometers, to improve the sensitivity and resolution of cell analysis. Research-grade flow cytometers are used in scientific studies to examine the physical and chemical properties of cells or particles as they pass through a fluid stream. These devices provide high sensitivity and resolution for multiparametric cellular analysis, featuring advanced optical systems and software that can detect multiple fluorescent markers. They are crucial in fields like immunology, oncology, and cell biology. For example, in March 2024, Beckman Coulter Life Sciences, a US-based company specializing in biomedical testing products, introduced the CytoFLEX nanoflow cytometer. This system is capable of detecting nanoparticles as small as 40 nm, making it highly effective for analyzing extracellular vesicles (EVs) and other nanoscale entities. It offers a sensitivity range from 1 µm to 40 nm, with a resolution of 10 nm, allowing for the detection of low-abundance cargo within EVs. This enhanced sensitivity is crucial for accurately characterizing small particle populations. The system features 6 fluorescent channels and 5 side scatter channels, enabling extensive data collection across multiple parameters simultaneously. It is also equipped with CytExpert nano software, which provides an intuitive interface for simplifying complex analyses while supporting advanced research.
Companies in the flow cytometry market are also focused on developing innovative products such as automated sample preparation systems to deliver faster, more accurate results while reducing hands-on time for technicians. An automated sample preparation system streamlines laboratory processes by automating tasks such as mixing, staining, and dilution, ensuring consistent and precise sample preparation. This not only minimizes manual effort but also enhances efficiency, making it ideal for high-throughput labs and clinical diagnostics. For example, in June 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD FACSDuet. This premium sample preparation system is designed to integrate seamlessly with the BD FACSLyric clinical flow cytometry system, enabling a fully automated "walkaway" workflow. It automates critical processes, including cocktailing, washing, and centrifuging of samples. Once prepared, the samples are transferred to the flow cytometer with no human intervention, reducing manual steps and hands-on time. This system significantly improves standardization and reproducibility in clinical diagnostics, boosting overall lab efficiency.
In February 2022, KCAS Bioanalytical and Biomarker Services, a US-based development service provider compliant with GLP and GCP standards, acquired FlowMetric LLC for an undisclosed amount. This acquisition is expected to bolster KCAS's capabilities in the field of analytical testing. FlowMetric is a US-based provider of flow cytometry and cellular assay services.
Major companies operating in the flow cytometry market include Beckman Coulter Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Sysmex Corporation, Merck KGaA, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., General Electric Company, EMD Millipore Corporation, Affymetrix Inc., Biomerieux SA, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS
North America was the largest region in the flow cytometry market in 2024. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the flow cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The flow cytometry market includes revenue earned by cytometry systems, panel builders, and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Flow Cytometry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on flow cytometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for flow cytometry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The flow cytometry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.